Source: International Congress 2017 – Lung fibrosis: basic science
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Hesse (HANNOVER, Germany). Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison. 919

Member's Comments

No comment yet.

Related content which might interest you: Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Potential therapeutic targets for lung repair during human ex vivo lung perfusion Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019 Year: 2020 Three-dimensional tissue-based models for translational lung stem cell research: precision-cut lung slices Source: Eur Respir Monogr 2021; 91: 222-231 Year: 2021 Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021 Induction of pro-fibrotic biomarkers in precision-cut lung slices (PCLS) Source: International Congress 2016 – IPF pathogenesis Year: 2016 Precision-cut lung slices as an in vitro model for testing of novel therapeutic agents Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Virus-mediated transformation of type 2 pneumocytes in ex vivo cultured lung slices Source: ERS Research Seminar 2016 - New developments in in vitro models of the pulmonary epithelium Year: 2016 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 An in vivo comparison of two lung function systems Source: Eur Respir J 2005; 26: Suppl. 49, 177s Year: 2005 Ex vivo elastase and hydrogen peroxide stimulation in lung slices: novel models to study lung repair Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 PP214 – Human precision-cut lung slices generated from excess donor lungs as a model for IPF and drug screening Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Characterisation of an ex vivo model of human airway epithelium Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Human lung scaffolds to model lung disease and tissue regeneration Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018 Neutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipients Source: Eur Respir J, 53 (4) 1801736; 10.1183/13993003.01736-2018 Year: 2019 The lung in a box: ex vivo monitoring of donor lungs and clinical implications for lung preservation, repair and utilisation Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century Year: 2021